Medicine bottles on a production line

Newly-launched NHS Commercial Framework to offer ‘welcome clarity’

The publication of a new NHS Commercial Framework for New Medicines has been welcomed by the industry as a way of providing clarity, support and a route to quicker adoption for new medicines.

The commercial framework was part of a commitment outlined by NHS England in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access, which would set out more operational detail on the commercial arrangements with the pharmaceutical industry.

The newly-outlined commercial framework:

  • Outlines the purpose and principles on which NHS commercial medicines activity will be based.
  • Defines the roles and responsibilities of those involved in commercial medicines activity and detailing how pharmaceutical companies can engage with the NHS.
  • Clarifies the routes to routine commissioning in the NHS, and where commercial activity can occur in those routes.
  • Outlines commercial flexibilities, and circumstances where they could be considered.

The draft framework was developed by NHS England, in conjunction with expertise from partners including NICE, the Department of Health and Social Care and the Office for Life Sciences.

It is intended to set out existing arrangements and provide further operational detail in a complimentary manner to the previously-released Voluntary Scheme.

In response to the framework’s publication, Chief Executive of the ABPI, Richard Torbett, said: “Today’s publication of the NHS commercial framework for new medicines provides welcome clarity on how companies can partner with the NHS and NICE to get new medicines to the patients who need them.

“As more new medicines are discovered, we need a system that can provide the right commercial flexibilities and that supports faster uptake and adoption of new treatments.

“The Framework provides important recognition of this, and the ABPI will work closely with NHS England as the Framework is reviewed and developed over time.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all